These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17979653)

  • 21. Nonclassical Zwitterions as a Design Principle to Reduce Lipophilicity without Impacting Permeability.
    Möbitz H; Dittrich B; Rodde S; Strang R
    J Med Chem; 2024 Jun; 67(11):9485-9494. PubMed ID: 38747896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case study of in silico modelling of ciprofloxacin hydrochloride/metallic compound interactions.
    Stojkovic A; Parojcic J; Djuric Z; Corrigan OI
    AAPS PharmSciTech; 2014 Apr; 15(2):270-8. PubMed ID: 24306676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges in Permeability Assessment for Oral Drug Product Development.
    Koziolek M; Augustijns P; Berger C; Cristofoletti R; Dahlgren D; Keemink J; Matsson P; McCartney F; Metzger M; Mezler M; Niessen J; Polli JE; Vertzoni M; Weitschies W; Dressman J
    Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on lipophilic efficiency as an important metric in drug design.
    Gallego RA; Edwards MP; Montgomery TP
    Expert Opin Drug Discov; 2024 Aug; 19(8):917-931. PubMed ID: 38919130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules.
    Daina A; Zoete V
    ChemMedChem; 2016 Jun; 11(11):1117-21. PubMed ID: 27218427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of intestinal pharmacokinetic natural product-drug interactions.
    Oyanna VO; Clarke JD
    Drug Metab Rev; 2024 Aug; ():1-17. PubMed ID: 39078118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of method suitability for drug permeability classification.
    Volpe DA
    AAPS J; 2010 Dec; 12(4):670-8. PubMed ID: 20811966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging therapeutic peptide transport across intestinal barriers.
    Larsen JB; Taebnia N; Dolatshahi-Pirouz A; Eriksen AZ; Hjørringgaard C; Kristensen K; Larsen NW; Larsen NB; Marie R; Mündler AK; Parhamifar L; Urquhart AJ; Weller A; Mortensen KI; Flyvbjerg H; Andresen TL
    RSC Chem Biol; 2021 Aug; 2(4):1115-1143. PubMed ID: 34458827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Bioavailability of Drugs-The Current State of Knowledge.
    Stielow M; Witczyńska A; Kubryń N; Fijałkowski Ł; Nowaczyk J; Nowaczyk A
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of subcutaneous drug absorption - Development of novel simulated interstitial fluid media for predictive subcutaneous in vitro assays.
    Torres-Terán I; Venczel M; Klein S
    Int J Pharm; 2024 Jun; 658():124227. PubMed ID: 38750979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Drug Solubility Studies Using Shake-Flask Versus a Laser-Based Robotic Method.
    Rahimpour E; Moradi M; Sheikhi-Sovari A; Rezaei H; Rezaei H; Jouyban-Gharamaleki V; Kuentz M; Jouyban A
    AAPS PharmSciTech; 2023 Oct; 24(7):207. PubMed ID: 37817041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Balanced Permeability Index: A Multiparameter Index for Improved In Vitro Permeability.
    Weiss DR; Baylon JL; Evans ED; Paiva A; Everlof G; Cutrone J; Broccatelli F
    ACS Med Chem Lett; 2024 Apr; 15(4):457-462. PubMed ID: 38628792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpreting the efficacy enhancement mechanism of Chinese medicine processing from a biopharmaceutic perspective.
    Yang B; Zhang Z; Song J; Qi T; Zeng J; Feng L; Jia X
    Chin Med; 2024 Jan; 19(1):14. PubMed ID: 38238801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.
    Amidon GL; Lennernäs H; Shah VP; Crison JR
    Pharm Res; 1995 Mar; 12(3):413-20. PubMed ID: 7617530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents.
    Preeti ; Sambhakar S; Malik R; Bhatia S; Harrasi AA; Saharan R; Aggarwal G; Kumar S; Sehrawat R; Rani C
    Int J Hypertens; 2024; 2024():2430147. PubMed ID: 38410720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caco-2 Cell Line Standardization with Pharmaceutical Requirements and In Vitro Model Suitability for Permeability Assays.
    Kus M; Ibragimow I; Piotrowska-Kempisty H
    Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo Approach.
    Lignet F; Sherbetjian E; Kratochwil N; Jones R; Suenderhauf C; Otteneder MB; Singer T; Parrott N
    Pharm Res; 2016 Oct; 33(10):2565-79. PubMed ID: 27469324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirements for the formal representation of pathophysiology mechanisms by clinicians.
    de Bono B; Helvensteijn M; Kokash N; Martorelli I; Sarwar D; Islam S; Grenon P; Hunter P
    Interface Focus; 2016 Apr; 6(2):20150099. PubMed ID: 27051514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.